Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Aspira Women's Health Inc.awh · Entity 7871 | Director | March 31, 2022 | April 05, 2022 |
| HTG MOLECULAR DIAGNOSTICS, INCHTGM · Entity 112530 | Director | August 18, 2021 | August 19, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Aspira Women's Health Inc.
Report date March 31, 2022 · Filed April 05, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 496,129 |
Reported balance
After 2022-03-31 transaction · row 1
1 source rowRow 1 · 2022-03-31 · Grant · Acquired 72,937 · Balance 496,129 F1: The restricted stock units will vest in four equal installments on April 1, 2022, June 1, 2022, September 1, 2022 and December 1, 2022. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.04 · Expires 2032-03-31 | Direct | 110,305 |
Reported balance
After 2022-03-31 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-03-31 · Grant · Acquired 110,305 · Balance 110,305 F2: The employee stock option will vest in four equal installments on April 1, 2022, June 1, 2022, September 1, 2022 and December 1, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock units will vest in four equal installments on April 1, 2022, June 1, 2022, September 1, 2022 and December 1, 2022.
F2: The employee stock option will vest in four equal installments on April 1, 2022, June 1, 2022, September 1, 2022 and December 1, 2022.
HTG MOLECULAR DIAGNOSTICS, INC
Report date August 18, 2021 · Filed August 19, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.25 · Expires 2031-08-17 | Direct | 4,000 |
Reported balance
After 2021-08-18 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-08-18 · Grant · Acquired 4,000 · Balance 4,000 F1: The shares will vest on the earlier of August 18, 2022 or the date of the next annual meeting of stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares will vest on the earlier of August 18, 2022 or the date of the next annual meeting of stockholders.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 31, 2022 Filed Apr 5, 2022 00:23 UTC | Aspira Women's Health Inc. awh · Entity 7871 | GrantEmployee Stock Option (Right to Buy) · Derivative | 110,305 | $0.00 Strike: $1.04 | $0.00 |
DisclosureSEC source: 0001162956-22-000001 · primary_doc.xml · derivative · entry 2 LAFRANCE JAMES T · CIK 0001162956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,305 Underlying: Common Stock · 110,305 shares Expires 2032-03-31 F2 · derivative.exercise_date: The employee stock option will vest in four equal installments on April 1, 2022, June 1, 2022, September 1, 2022 and December 1, 2022. Read SEC document |
| March 31, 2022 Filed Apr 5, 2022 00:23 UTC | Aspira Women's Health Inc. awh · Entity 7871 | GrantCommon Stock | 72,937 | $0.00 | $0.00 |
DisclosureSEC source: 0001162956-22-000001 · primary_doc.xml · nonDerivative · entry 1 LAFRANCE JAMES T · CIK 0001162956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 496,129 F1 · shares: The restricted stock units will vest in four equal installments on April 1, 2022, June 1, 2022, September 1, 2022 and December 1, 2022. Read SEC document |
| August 18, 2021 Filed Aug 19, 2021 17:17 UTC | HTG MOLECULAR DIAGNOSTICS, INC HTGM · Entity 112530 | GrantStock Option (right to buy) · Derivative | 4,000 | $0.00 Strike: $6.25 | $0.00 |
DisclosureSEC source: 0001209191-21-052582 · doc4.xml · derivative · entry 1 LAFRANCE JAMES T · CIK 0001162956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 4,000 shares Expires 2031-08-17 F1 · derivative.exercise_date: The shares will vest on the earlier of August 18, 2022 or the date of the next annual meeting of stockholders. Read SEC document |
| June 24, 2021 Filed Sep 16, 2021 22:14 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | GrantEmployee Stock Option (Right To Buy) · Derivative | 502 | $0.00 Strike: $5.90 | $0.00 |
DisclosureSEC source: 0001162956-21-000003 · primary_doc.xml · derivative · entry 2 LAFRANCE JAMES T · CIK 0001162956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 502 Underlying: Common Stock · 502 shares Expires 2031-06-24 F2 · derivative.exercise_date: The employee stock option will vest in two equal installments on September 1, 2021 and December 1, 2021 Read SEC document |
| June 24, 2021 Filed Sep 16, 2021 22:14 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | GrantCommon Stock | 330 | $0.00 | $0.00 |
DisclosureSEC source: 0001162956-21-000003 · primary_doc.xml · nonDerivative · entry 1 LAFRANCE JAMES T · CIK 0001162956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 423,192 F1 · shares: The restricted stock units will vest in two equal installments on September 1, 2021 and December 1, 2021. Read SEC document |
| May 06, 2021 Filed Sep 16, 2021 22:06 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | GrantEmployee Stock Option (Right To Buy) · Derivative | 720 | $0.00 Strike: $4.92 | $0.00 |
DisclosureSEC source: 0001162956-21-000002 · primary_doc.xml · derivative · entry 2 LAFRANCE JAMES T · CIK 0001162956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 720 Underlying: Common Stock · 720 shares Expires 2031-05-06 F2 · derivative.exercise_date: The employee stock option will vest in three equal installments on June 1, 2021, September 1, 2021 and December 1, 2021 Read SEC document |
| May 06, 2021 Filed Sep 16, 2021 22:06 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | GrantCommon Stock | 423 | $0.00 | $0.00 |
DisclosureSEC source: 0001162956-21-000002 · primary_doc.xml · nonDerivative · entry 1 LAFRANCE JAMES T · CIK 0001162956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 422,862 F1 · shares: The restricted stock units will vest in three equal installments on June 1, 2021, September 1, 2021 and December 1, 2021. Read SEC document |
| March 19, 2021 Filed Mar 23, 2021 21:03 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | GrantEmployee Stock Option (Right to Buy) · Derivative | 15,412 | $0.00 Strike: $7.40 | $0.00 |
DisclosureSEC source: 0001162956-21-000001 · primary_doc.xml · derivative · entry 2 LAFRANCE JAMES T · CIK 0001162956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,412 Underlying: Common Stock · 15,412 shares Expires 2031-03-19 F3 · derivative.exercise_date: The employee stock option will vest in four equal installments on April 1, 2021, June 1, 2021, September 1, 2021 and December 1, 2021. Read SEC document |
| March 19, 2021 Filed Mar 23, 2021 21:03 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | GrantCommon Stock | 9,205 | $0.00 | $0.00 |
DisclosureSEC source: 0001162956-21-000001 · primary_doc.xml · nonDerivative · entry 1 LAFRANCE JAMES T · CIK 0001162956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 422,439 F1 · shares: The shares of common stock represent restricted stock units with the contingent right to receive one share of common stock of Aspira Women's Health Inc. for each restricted stock unit. The restricted stock units will vest in four equal installments on April 1, 2021, June 1, 2021, September 1, 2021 and December 1, 2021. F2 · balance_after: Total reflects the adjustment of 21,246 shares of common stock previously reported as part of a restricted stock unit grant made on March 19, 2020. Read SEC document |
| August 19, 2020 Filed Aug 21, 2020 17:38 UTC | HTG MOLECULAR DIAGNOSTICS, INC HTGM · Entity 112530 | GrantStock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $0.46 | $0.00 |
DisclosureSEC source: 0001209191-20-047983 · doc4.xml · derivative · entry 1 LAFRANCE JAMES T · CIK 0001162956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2030-08-18 F1 · derivative.exercise_date: The shares will vest on the earlier of August 19, 2021 or the date of the next annual meeting of stockholders. Read SEC document |
| June 02, 2020 Filed Jun 5, 2020 01:54 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | OtherWarrants to acquire stock · Derivative | 5,210 | $0.13 Strike: $1.80 | $651.25 |
DisclosureSEC source: 0001162956-20-000002 · primary_doc.xml · derivative · entry 2 LAFRANCE JAMES T · CIK 0001162956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,210 shares Expires 2020-06-08 Read SEC document |
| June 02, 2020 Filed Jun 5, 2020 01:54 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | OtherCommon Stock | 5,210 | $1.80 | $9,378.00 |
DisclosureSEC source: 0001162956-20-000002 · primary_doc.xml · nonDerivative · entry 1 LAFRANCE JAMES T · CIK 0001162956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 434,480 Read SEC document |
| June 02, 2020 Filed Jun 10, 2020 00:44 UTC Amendment | Aspira Women's Health Inc. vrml · Entity 7871 | OtherWarrants to acquire Common Stock · Derivative | 5,021 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0001162956-20-000003 · primary_doc.xml · derivative · entry 2 LAFRANCE JAMES T · CIK 0001162956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,021 shares Expires 2020-06-08 F1 · derivative.underlying_shares: This amendment is being filed to correct an error in the number of shares of common stock and warrants previously reported, which were inadvertently over-reported in the original Form 4 filing as a result of a transposition of the numbers. Read SEC document |
| June 02, 2020 Filed Jun 10, 2020 00:44 UTC Amendment | Aspira Women's Health Inc. vrml · Entity 7871 | OtherCommon Stock | 5,021 | $1.80 | $9,037.80 |
DisclosureSEC source: 0001162956-20-000003 · primary_doc.xml · nonDerivative · entry 1 LAFRANCE JAMES T · CIK 0001162956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 434,480 F1 · shares: This amendment is being filed to correct an error in the number of shares of common stock and warrants previously reported, which were inadvertently over-reported in the original Form 4 filing as a result of a transposition of the numbers. Read SEC document |
| March 19, 2020 Filed Mar 23, 2020 20:55 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | GrantEmployee Stock Option (Right to Buy) · Derivative | 147,783 | $0.00 Strike: $0.68 | $0.00 |
DisclosureSEC source: 0001162956-20-000001 · primary_doc.xml · derivative · entry 2 LAFRANCE JAMES T · CIK 0001162956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,783 Underlying: Common Stock · 147,783 shares Expires 2030-03-19 F2 · derivative.exercise_date: The employee stock option will vest in four equal installments on April 1, 2020, June 1, 2020, September 1, 2020 and December 1, 2020. Read SEC document |
| March 19, 2020 Filed Mar 23, 2020 20:55 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | GrantCommon Stock | 84,986 | $0.00 | $0.00 |
DisclosureSEC source: 0001162956-20-000001 · primary_doc.xml · nonDerivative · entry 1 LAFRANCE JAMES T · CIK 0001162956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 429,459 F1 · shares: The shares of common stock represent restricted stock units with contingent right to receive one share of common stock of Vermillion, Inc. for each restricted stock unit. The restricted stock units will vest in four equal installments on April 1, 2020, June 1, 2020, September 1, 2020 and December 1, 2020. Read SEC document |
| August 14, 2019 Filed Aug 16, 2019 16:21 UTC | HTG MOLECULAR DIAGNOSTICS, INC HTGM · Entity 112530 | GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $1.04 | $0.00 |
DisclosureSEC source: 0001209191-19-046316 · doc4.xml · derivative · entry 2 LAFRANCE JAMES T · CIK 0001162956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-08-13 F1 · derivative.exercise_date: The shares will vest on the earlier of August 14, 2020 or the date of the next annual meeting of stockholders. Read SEC document |
| August 14, 2019 Filed Aug 16, 2019 16:21 UTC | HTG MOLECULAR DIAGNOSTICS, INC HTGM · Entity 112530 | GrantCommon Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-046316 · doc4.xml · nonDerivative · entry 1 LAFRANCE JAMES T · CIK 0001162956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Read SEC document |
| March 26, 2019 Filed Mar 28, 2019 22:33 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | GrantEMPLOYEE STOCK OPTION (RIGHT TO BUY) · Derivative | 119,284 | $0.00 Strike: $1.29 | $0.00 |
DisclosureSEC source: 0001162956-19-000001 · primary_doc.xml · derivative · entry 2 LAFRANCE JAMES T · CIK 0001162956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,284 Underlying: Common Stock · 119,284 shares Expires 2029-03-26 F2 · derivative.exercise_date: The employee stock option will vest in four equal installments on April 1, 2019, June 1, 2019, September 1, 2019 and December 1, 2019. Read SEC document |
| March 26, 2019 Filed Mar 28, 2019 22:33 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | GrantCommon Stock | 45,455 | $0.00 | $0.00 |
DisclosureSEC source: 0001162956-19-000001 · primary_doc.xml · nonDerivative · entry 1 LAFRANCE JAMES T · CIK 0001162956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 343,473 F1 · shares: The shares of common stock represent restricted stock units with contingent right to receive one share of common stock of Vermillion, Inc. for each restricted stock unit. The restricted stock units will vest in four equal installments on April 1, 2019, June 1, 2019, September 1, 2019 and December 1, 2019. Read SEC document |
| March 26, 2019 Filed Apr 12, 2019 12:37 UTC Amendment | Aspira Women's Health Inc. VRML · Entity 7871 | GrantEMPLOYEE STOCK OPTION (RIGHT TO BUY) · Derivative | 119,284 | $0.00 Strike: $1.29 | $0.00 |
DisclosureSEC source: 0001162956-19-000002 · primary_doc.xml · derivative · entry 2 LAFRANCE JAMES T · CIK 0001162956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,284 Underlying: Common Stock · 119,284 shares Expires 2029-03-26 F2 · derivative.exercise_date: The employee stock option will vest in four equal installments on April 1, 2019, June 1, 2019, September 1, 2019 and December 1, 2019. Read SEC document |
| March 26, 2019 Filed Apr 12, 2019 12:37 UTC Amendment | Aspira Women's Health Inc. VRML · Entity 7871 | GrantCommon Stock | 45,455 | $0.00 | $0.00 |
DisclosureSEC source: 0001162956-19-000002 · primary_doc.xml · nonDerivative · entry 1 LAFRANCE JAMES T · CIK 0001162956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 344,473 F1 · shares: The shares of common stock represent restricted stock units with contingent right to receive one share of common stock of Vermillion, Inc. for each restricted stock unit. The restricted stock units will vest in four equal installments on April 1, 2019, June 1, 2019, September 1, 2019 and December 1, 2019. Read SEC document |
| August 20, 2018 Filed Aug 22, 2018 00:57 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | SaleCommon Stock | 2,900 | $0.54 | $1,566.00 |
DisclosureSEC source: 0001162956-18-000002 · primary_doc.xml · nonDerivative · entry 4 LAFRANCE JAMES T · CIK 0001162956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 298,018 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5 · price: The sale reported in column 4 is a weighted average price. The shares were sold in multiple transactions at $0.5375 per share. The reporting person undertakes to provide to Vermillion, any security holder of Vermillion or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. Read SEC document |
| August 17, 2018 Filed Aug 22, 2018 00:57 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | SaleCommon Stock | 7,500 | $0.51 | $3,825.00 |
DisclosureSEC source: 0001162956-18-000002 · primary_doc.xml · nonDerivative · entry 3 LAFRANCE JAMES T · CIK 0001162956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,918 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · price: The sale reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.5059 to $0.5150 per share. The reporting person undertakes to provide to Vermillion, any security holder of Vermillion or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. Read SEC document |
| August 15, 2018 Filed Aug 17, 2018 17:31 UTC | HTG MOLECULAR DIAGNOSTICS, INC HTGM · Entity 112530 | GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $3.31 | $0.00 |
DisclosureSEC source: 0001209191-18-047488 · doc4.xml · derivative · entry 2 LAFRANCE JAMES T · CIK 0001162956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2028-08-14 F1 · derivative.exercise_date: The shares will vest on the earlier of August 15, 2019 or the date of the next annual meeting of stockholders. Read SEC document |
| August 15, 2018 Filed Aug 17, 2018 17:31 UTC | HTG MOLECULAR DIAGNOSTICS, INC HTGM · Entity 112530 | GrantCommon Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-047488 · doc4.xml · nonDerivative · entry 1 LAFRANCE JAMES T · CIK 0001162956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Read SEC document |
| August 15, 2018 Filed Aug 22, 2018 00:57 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | SaleCommon Stock | 10,427 | $0.49 | $5,109.23 |
DisclosureSEC source: 0001162956-18-000002 · primary_doc.xml · nonDerivative · entry 2 LAFRANCE JAMES T · CIK 0001162956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 301,418 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The sale reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.4710 to $0.5150 per share. The reporting person undertakes to provide to Vermillion, any security holder of Vermillion or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. Read SEC document |
| August 14, 2018 Filed Aug 22, 2018 00:57 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | SaleCommon Stock | 2,573 | $0.51 | $1,312.23 |
DisclosureSEC source: 0001162956-18-000002 · primary_doc.xml · nonDerivative · entry 1 LAFRANCE JAMES T · CIK 0001162956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 318,845 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The sale reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.5150 to $0.5156 per share. The reporting person undertakes to provide to Vermillion, any security holder of Vermillion or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. Read SEC document |
| April 13, 2018 Filed Apr 17, 2018 20:27 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | GrantCommon Stock | 96,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001162956-18-000001 · primary_doc.xml · nonDerivative · entry 1 LAFRANCE JAMES T · CIK 0001162956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 321,418 F1 · shares: The shares of common stock represent restricted stock units with contingent right to receive one share of common stock of Vermillion, Inc. for each restricted stock unit. 50% of the restricted stock units will vest on June 1, 2018, 25% of the restricted stock units will vest on September 1, 2018 and 25% of the restricted stock units will vest on December 1, 2018. Read SEC document |
| August 23, 2017 Filed Aug 24, 2017 17:14 UTC | HTG MOLECULAR DIAGNOSTICS, INC HTGM · Entity 112530 | GrantCommon Stock | 7,500 | $2.05 | $15,375.00 |
DisclosureSEC source: 0001209191-17-050169 · doc4.xml · nonDerivative · entry 1 LAFRANCE JAMES T · CIK 0001162956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 F1 · shares: The shares were acquired by the Reporting Person pursuant to the Issuer's Amended and Restated Stock Purchase Plan adopted December 1, 2015, as amended January 21, 2016. Read SEC document |
| August 15, 2017 Filed Aug 16, 2017 16:30 UTC | HTG MOLECULAR DIAGNOSTICS, INC HTGM · Entity 112530 | GrantStock Option (right to buy) · Derivative | 6,000 | $0.00 Strike: $2.27 | $0.00 |
DisclosureSEC source: 0001209191-17-049212 · doc4.xml · derivative · entry 1 LAFRANCE JAMES T · CIK 0001162956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires 2027-08-14 F1 · derivative.exercise_date: The shares will vest monthly in equal installments over a one-year period such that the stock option is fully vested on August 15, 2018. Read SEC document |
| March 23, 2017 Filed Mar 27, 2017 20:55 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | GrantCommon Stock | 35,324 | $0.00 | $0.00 |
DisclosureSEC source: 0001162956-17-000002 · primary_doc.xml · nonDerivative · entry 1 LAFRANCE JAMES T · CIK 0001162956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,418 F1 · shares: The shares of common stock represent restricted stock units with contingent right to receive one share of common stock of Vermillion, Inc. for each restricted stock unit. 50% of the restricted stock units will vest on June 1, 2017, 25% of the restricted stock units will vest on September 1, 2017 and 25% of the restricted stock units will vest on December 1, 2017. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 21:17 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | PurchaseWarrants (Right to buy) · Derivative | 5,021 | $0.13 Strike: $1.80 | $627.63 |
DisclosureSEC source: 0001162956-17-000001 · primary_doc.xml · derivative · entry 2 LAFRANCE JAMES T · CIK 0001162956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,021 Underlying: Common Stock · 5,021 shares Expires 2022-02-17 Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 21:17 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | PurchaseCommon Stock, par value $0.001 | 6,695 | $1.40 | $9,373.00 |
DisclosureSEC source: 0001162956-17-000001 · primary_doc.xml · nonDerivative · entry 1 LAFRANCE JAMES T · CIK 0001162956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,094 Read SEC document |
| August 26, 2016 Filed Sep 8, 2016 17:47 UTC Amendment | HTG MOLECULAR DIAGNOSTICS, INC HTGM · Entity 112530 | GrantStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $2.46 | $0.00 |
DisclosureSEC source: 0001209191-16-140610 · doc4a.xml · derivative · entry 1 LAFRANCE JAMES T · CIK 0001162956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2026-08-25 F1 · derivative.exercise_date: This Form 4 is being amended to correct the vesting schedule of the stock option as follows: One third of the shares vest on December 1, 2016 and the remaining shares will vest monthly in equal installments over a two year period such that the stock option is fully vested on December 1, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.